DNA and RNA analysis of genes for somatic mutations to provide targeted therapy for solid tumors plus PDL1 and MSI if requested
Sample Type - FFPE Block/Plasma
Can identify both Germline & Somatic Mutations, but cannot differentiate between the two | for identification of individuals who can benefit from PARP Inhibitor treatment
Sample Type - FFPE Block/Plasma
Analysis of 52 Genes with known therapeutic relevance to solid tumors | covers SNPS, INDELS, FUSIONS, CNVS | Includes NTRK Fusions
Sample Type - FFPE Block/Plasma
Can be done on either solid tissue or blood | UK-EQAS Accredited
Sample Type - FFPE Block/Plasma
Covers 15 relevant mutations for breast, colorectal , gastic , lung, brain, endometrial , ovarian cancer
Sample Type - FFPE Block/Plasma
Recommended for metastatic colorectal cancer
Sample Type - FFPE Block/Plasma
Tissue agnostic marker for identification of patients for immunotherapy recommended in colorectal gastric, breast, prostate, cholangiocarcinoma, bladder & more
Sample Type - FFPE Block/Plasma
Qualitative,Quantitative
Sample Type - Whole Blood/Bone Marrow Aspirate
Qualitative, Recommended in Myeloproliferative
Sample Type - Whole Blood/Bone Marrow Aspirate
Qualitative, For profiling of Leukemia
Sample Type - Whole Blood/Bone Marrow Aspirate
AML1-ETO, CBFB-MYTH11, NPM1, FLT3, CEBPA
Sample Type - Whole Blood/Bone Marrow Aspirate
Therapeutic Potential in leukemia and gliomas
Sample Type - Whole Blood/Bone Marrow Aspirate